FineMark National Bank & Trust’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $18.6M | Buy |
81,449
+2,476
| +3% | +$564K | 0.58% | 43 |
|
|
2025
Q3 | $18.3M | Sell |
78,973
-2,019
| -2% | -$411K | 0.6% | 41 |
|
|
2025
Q2 | $15M | Buy |
80,992
+44
| +0.1% | +$8.18K | 0.51% | 56 |
|
|
2025
Q1 | $17M | Sell |
80,948
-13,644
| -14% | -$2.65M | 0.62% | 40 |
|
|
2024
Q4 | $16.8M | Sell |
94,592
-2,094
| -2% | -$385K | 0.59% | 49 |
|
|
2024
Q3 | $19.1M | Buy |
96,686
+1,187
| +1% | +$222K | 0.66% | 38 |
|
|
2024
Q2 | $16.4M | Buy |
95,499
+1,613
| +2% | +$267K | 0.6% | 45 |
|
|
2024
Q1 | $17.1M | Buy |
93,886
+2,185
| +2% | +$377K | 0.64% | 38 |
|
|
2023
Q4 | $14.2M | Sell |
91,701
-2,114
| -2% | -$308K | 0.58% | 45 |
|
|
2023
Q3 | $14M | Buy |
93,815
+11,620
| +14% | +$1.71M | 0.61% | 39 |
|
|
2023
Q2 | $11.1M | Buy |
82,195
+4,584
| +6% | +$672K | 0.46% | 56 |
|
|
2023
Q1 | $12.4M | Buy |
77,611
+32,990
| +74% | +$5.04M | 0.53% | 50 |
|
|
2022
Q4 | $7.21M | Sell |
44,621
-44
| -0.1% | -$6.75K | 0.32% | 80 |
|
|
2022
Q3 | $5.99M | Buy |
44,665
+196
| +0.4% | +$28.1K | 0.29% | 84 |
|
|
2022
Q2 | $6.81M | Sell |
44,469
-920
| -2% | -$141K | 0.3% | 82 |
|
|
2022
Q1 | $7.36M | Sell |
45,389
-499
| -1% | -$72.5K | 0.29% | 79 |
|
|
2021
Q4 | $6.21M | Sell |
45,888
-941
| -2% | -$111K | 0.24% | 92 |
|
|
2021
Q3 | $5.05M | Buy |
46,829
+2,767
| +6% | +$316K | 0.21% | 97 |
|
|
2021
Q2 | $4.96M | Sell |
44,062
-1,095
| -2% | -$123K | 0.2% | 103 |
|
|
2021
Q1 | $4.89M | Buy |
45,157
+1,507
| +3% | +$161K | 0.21% | 101 |
|
|
2020
Q4 | $4.68M | Buy |
43,650
+3,098
| +8% | +$298K | 0.21% | 91 |
|
|
2020
Q3 | $3.55M | Buy |
40,552
+892
| +2% | +$84K | 0.17% | 96 |
|
|
2020
Q2 | $3.89M | Buy |
39,660
+384
| +1% | +$33.8K | 0.22% | 92 |
|
|
2020
Q1 | $2.99M | Buy |
39,276
+506
| +1% | +$43.1K | 0.19% | 97 |
|
|
2019
Q4 | $3.43M | Sell |
38,770
-701
| -2% | -$58.2K | 0.17% | 102 |
|
|
2019
Q3 | $2.99M | Buy |
39,471
+953
| +2% | +$65.3K | 0.16% | 106 |
|
|
2019
Q2 | $2.8M | Buy |
38,518
+7,037
| +22% | +$553K | 0.16% | 105 |
|
|
2019
Q1 | $2.54M | Sell |
31,481
-6,067
| -16% | -$496K | 0.15% | 105 |
|
|
2018
Q4 | $3.46M | Sell |
37,548
-1,740
| -4% | -$153K | 0.23% | 87 |
|
|
2018
Q3 | $3.72M | Sell |
39,288
-64,901
| -62% | -$6.15M | 0.23% | 92 |
|
|
2018
Q2 | $9.65M | Buy |
104,189
+11
| +0% | +$1.07K | 0.59% | 36 |
|
|
2018
Q1 | $9.86M | Sell |
104,178
-1,746
| -2% | -$192K | 0.63% | 36 |
|
|
2017
Q4 | $10.2M | Sell |
105,924
-4,473
| -4% | -$422K | 0.65% | 35 |
|
|
2017
Q3 | $9.81M | Sell |
110,397
-5,254
| -5% | -$400K | 0.65% | 34 |
|
|
2017
Q2 | $8.39M | Sell |
115,651
-96
| -0.1% | -$6.45K | 0.6% | 38 |
|
|
2017
Q1 | $7.54M | Sell |
115,747
-2,109
| -2% | -$133K | 0.55% | 41 |
|
|
2016
Q4 | $7.38M | Buy |
117,856
+55,321
| +88% | +$3.38M | 0.59% | 38 |
|
|
2016
Q3 | $3.94M | Buy |
62,535
+11,560
| +23% | +$748K | 0.42% | 66 |
|
|
2016
Q2 | $3.16M | Sell |
50,975
-1,034
| -2% | -$63K | 0.35% | 78 |
|
|
2016
Q1 | $2.97M | Sell |
52,009
-9,484
| -15% | -$529K | 0.35% | 78 |
|
|
2015
Q4 | $3.64M | Sell |
61,493
-3,589
| -6% | -$207K | 0.44% | 65 |
|
|
2015
Q3 | $3.54M | Buy |
65,082
+6,263
| +11% | +$408K | 0.48% | 60 |
|
|
2015
Q2 | $3.95M | Sell |
58,819
-943
| -2% | -$61.6K | 0.52% | 58 |
|
|
2015
Q1 | $3.5M | Sell |
59,762
-1,829
| -3% | -$110K | 0.48% | 59 |
|
|
2014
Q4 | $4.03M | Buy |
61,591
+23,234
| +61% | +$1.46M | 0.59% | 44 |
|
|
2014
Q3 | $2.22M | Sell |
38,357
-345
| -0.9% | -$19.2K | 0.35% | 77 |
|
|
2014
Q2 | $2.18M | Sell |
38,702
-333
| -0.9% | -$17.5K | 0.37% | 76 |
|
|
2014
Q1 | $2.01M | Sell |
39,035
-1,093
| -3% | -$55.2K | 0.38% | 65 |
|
|
2013
Q4 | $2.12M | Buy |
40,128
+3,749
| +10% | +$184K | 0.44% | 54 |
|
|
2013
Q3 | $1.63M | Buy |
36,379
+2,170
| +6% | +$96.2K | 0.4% | 59 |
|
|
2013
Q2 | $1.41M | Buy |
+34,209
| New | +$1.5M | 0.43% | 55 |
|
Other funds holding ABBV
FineMark National Bank & Trust's ABBV Position: Q4 2025 in Review
FineMark National Bank & Trust increased its AbbVie (ABBV) stake by 3.1% in Q4 2025, buying an estimated $564K and bringing the position to 81,449 shares worth $18.6M. The position accounts for 0.58% of the portfolio, ranked #43.
FineMark National Bank & Trust first reported a position in ABBV in Q2 2013 and has held it in 51 quarters since. The position peaked at $19.1M in Q3 2024. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.
- FineMark National Bank & Trust held 81,449 shares of AbbVie worth $18.6M as of Q4 2025.
- FineMark National Bank & Trust bought 2,476 AbbVie shares in Q4 2025, an estimated $564K.
- AbbVie made up 0.58% of FineMark National Bank & Trust's portfolio in Q4 2025, its #43 holding.
- FineMark National Bank & Trust first reported a position in AbbVie in Q2 2013 and has held it in 51 quarters since.
- FineMark National Bank & Trust's AbbVie position peaked at $19.1M in Q3 2024.
- 4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.
Based on FineMark National Bank & Trust's 13F filing for Q4 2025, filed 12 Feb 2026.